India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.
India's Zydus Life posts Q2 profit rise on steady US demand November 12, 2024 Indian generic drugmaker Lupin reported a bigger-than-expected rise in second-quarter profit on Thursday, driven by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback